SMTL ID : 8ifr.1

SARS-CoV-2 3CL protease (3CLpro) in complex with compound 3

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 1.66 Å
Oligo State
homo-dimer
Ligands
2 x P0O: (1R,2S,5S)-3-[(2S)-2-(tert-butylcarbamoylamino)-3,3-dimethyl-butanoyl]-6,6-dimethyl-N-[(2S)-5-oxidanylidene-1-[(3S)-2-oxidanylidenepyrrolidin-3-yl]hex-3-en-2-yl]-3-azabicyclo[3.1.0]hexane-2-carboxamide(Covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Jiang, X. et al., Discovery of oral simnotrelvir, an approved SARS-CoV-2 3C-like protease inhibitor for the treatment of COVID-19. To Be Published
Release Date
2023-10-18
Peptides
3C-like proteinase nsp5: AB
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A
B
A

3C-like proteinase nsp5

Toggle Identical (AB)

Related Entries With Identical Sequence

5r7y.1 | 5r7z.1 | 5r80.1 | 5r81.1 | 5r82.1 | 5r83.1 | 5r84.1 | 5r8t.1 | 5re4.1 | 5re5.1 | 5re6.1 | 5re7.1 | 5re8.1 | 5re9.1 | 5rea.1 | 5reb.1 | 5rec.1 | 5red.1 | 5ree.1 | 5ref.1 | 5reg.1 | 5reh.1 | 5rei.1 | 5rej.1 | 5rek.1 | 5rel.1 | 5rem.1 | 5ren.1 | 5reo.1 | 5rep.1  more...